{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:41:18Z","timestamp":1790912478423,"version":"4.1.0"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2020,12,30]],"date-time":"2020-12-30T00:00:00Z","timestamp":1609286400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Varicella zoster virus (VZV) has been associated with giant cell arteritis (GCA). The introduction of a live attenuated vaccine against this virus (ZVL) might have changed the incidence of GCA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The incidence of GCA was retrospectively measured using 2 matched cohorts seen in a regional health system located in the Midwestern United States: ZVL recipients from the years 2007 through 2015 following the introduction of the vaccine and nonrecipients from the years 2000 through 2015.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In the ZVL cohort, a significant increase of GCA was associated with clinical criteria alone for the diagnosis of GCA (hazard ratio [HR], 2.70; 95% CI, 1.48\u20134.45; P = .004). In addition, using only pathologically confirmed GCA, the same matched cohort comparison analysis also found that ZVL recipients were at significantly higher risk than those who did not receive ZVL (HR, 2.70; 95% CI, 1.48\u20134.95; P = .001).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Using a matched cohort, retrospective comparison, ZVL was associated with an increased incidence of GCA.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofaa647","type":"journal-article","created":{"date-parts":[[2020,12,30]],"date-time":"2020-12-30T19:28:24Z","timestamp":1609356504000},"source":"Crossref","is-referenced-by-count":11,"title":["Increased Incidence of Giant Cell Arteritis After Introduction of a Live Varicella Zoster Virus Vaccine"],"prefix":"10.1093","volume":"8","author":[{"given":"William A","family":"Agger","sequence":"first","affiliation":[{"name":"Department of Infectious Disease, Gundersen Health System, La Crosse, Wisconsin, USA"},{"name":"Department of Medical Research, Gundersen Health System, La Crosse, Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jake A","family":"Deviley","sequence":"additional","affiliation":[{"name":"Department of Medical Research, Gundersen Health System, La Crosse, Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Borgert","sequence":"additional","affiliation":[{"name":"Department of Medical Research, Gundersen Health System, La Crosse, Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cary M","family":"Rasmussen","sequence":"additional","affiliation":[{"name":"Department of Medical Research, Gundersen Health System, La Crosse, Wisconsin, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,12,30]]},"reference":[{"key":"2021021017312070400_CIT0001","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2217\/fvl.10.90","article-title":"Varicella zoster virus latency","volume":"6","author":"Eshleman","year":"2011","journal-title":"Future Virol"},{"key":"2021021017312070400_CIT0002","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1600-065X.2011.01074.x","article-title":"Immune modulation during latent herpesvirus infection","volume":"245","author":"White","year":"2012","journal-title":"Immunol Rev"},{"key":"2021021017312070400_CIT0003","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1086\/320169","article-title":"Herpes zoster in older adults","volume":"32","author":"Yoshikawa","year":"2001","journal-title":"Clin Infect Dis"},{"key":"2021021017312070400_CIT0004","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s13365-018-0697-2","article-title":"Recurrent strokes, central nervous system vasculitis, and acquired protein S deficiency secondary to varicella zoster in a child with AIDS","volume":"25","author":"Deviley","year":"2019","journal-title":"J Neurovirol"},{"key":"2021021017312070400_CIT0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/cid\/ciz769","article-title":"Incidence of hospitalizations and emergency department visits for herpes zoster in immunocompromised and immunocompetent adults in Ontario, Canada, 2002-2016","volume":"71","author":"Buchan","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2021021017312070400_CIT0006","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/infdis\/jiy425","article-title":"Varicella zoster virus vasculopathy","volume":"218","author":"Nagel","year":"2018","journal-title":"J Infect Dis"},{"key":"2021021017312070400_CIT0007","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/jmv.21092","article-title":"Infection and temporal arteritis: a PCR-based study to detect pathogens in temporal artery biopsy specimens","volume":"80","author":"Cooper","year":"2008","journal-title":"J Med Virol"},{"key":"2021021017312070400_CIT0008","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/ard.2004.025320","article-title":"Human parvovirus B19, varicella zoster virus, and human herpes virus 6 in temporal artery biopsy specimens of patients with giant cell arteritis: analysis with quantitative real time polymerase chain reaction","volume":"64","author":"Alvarez-Lafuente","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"2021021017312070400_CIT0009","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1001\/jamaneurol.2015.2101","article-title":"Analysis of varicella-zoster virus in temporal arteries biopsy positive and negative for giant cell arteritis","volume":"72","author":"Nagel","year":"2015","journal-title":"JAMA Neurol"},{"key":"2021021017312070400_CIT0010","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1093\/infdis\/jiu542","article-title":"Varicella zoster virus in temporal arteries of patients with giant cell arteritis","volume":"212","author":"Gilden","year":"2015","journal-title":"J Infect Dis"},{"key":"2021021017312070400_CIT0011","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/BOR.0000000000000292","article-title":"Varicella zoster virus triggers the immunopathology of giant cell arteritis","volume":"28","author":"Gilden","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"2021021017312070400_CIT0012","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/infdis\/jiy382","article-title":"Herpes zoster vaccines","volume":"218","author":"Cunningham","year":"2018","journal-title":"J Infect Dis"},{"key":"2021021017312070400_CIT0013","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/art.1780330810","article-title":"The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"2021021017312070400_CIT0014","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jns.2017.01.053","article-title":"Giant cell arteritis following varicella zoster vaccination","volume":"375","author":"Lotan","year":"2017","journal-title":"J Neurol Sci"},{"key":"2021021017312070400_CIT0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ajo.2017.12.017","article-title":"Identification of herpes zoster-associated temporal arteritis among cases of giant cell arteritis","volume":"187","author":"Buckingham","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"2021021017312070400_CIT0016","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/01658107.2019.1604763","article-title":"Varicella zoster virus in giant cell arteritis: a review of current medical literature","volume":"43","author":"Ostrowski","year":"2019","journal-title":"Neuroophthalmology"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofaa647\/35292866\/ofaa647.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/8\/2\/ofaa647\/36228695\/ofaa647.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/8\/2\/ofaa647\/36228695\/ofaa647.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T08:46:33Z","timestamp":1613033193000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofaa647\/6055601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,30]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofaa647","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,2,1]]},"published":{"date-parts":[[2020,12,30]]},"article-number":"ofaa647"}}